Global health agencies are tracking the BA.3.2 variant, nicknamed 'cicada,' which has been identified in more than 20 U.S. states and over 20 countries. Its mutations could allow partial immune escape, prompting heightened monitoring of cases, wastewater and hospital metrics; current assessments suggest limited immediate additional risk but vigilance continues. Reports of co-circulation with seasonal flu underline the importance of tracking multiple respiratory viruses at once.
Click a connection line between nodes to view confidence and evidence.